The science of cryopreservation.

An overview of where cryopreservation stands today, the concepts that make it work, and where Noah's rigorous research is taking the field next.

Cryopreservation is the art of stopping biological time.

Cryopreservation means cooling biological material to temperatures where biochemical activity effectively halts. Stored below roughly −130°C, well-preserved tissue can remain intact for decades or longer instead of continuing to degrade.

Clinical cryopreservation already works routinely for embryos, sperm, eggs, stem cells, and some tissues. The frontier is scale: preserving complexity, vascular networks, and coordinated organ function without structural compromise.

Vitrification turns water into glass instead of ice.

Slow freezing lets ice crystals form and damage tissue. Vitrification avoids that pathway: cryoprotectants and rapid cooling solidify water as a glass, an amorphous solid with no ice. Gregory Fahy and colleagues showed in 1984 that this approach could preserve large organs without ice-related structural damage, reframing what cryobiologists thought was possible.

Vitrification is now used in fertility medicine, vascular graft banking, and experimental organ cryopreservation. The same chemicals that prevent ice can harm cells if concentrations or exposure times are wrong, so perfusion, staged loading, and rewarming matter as much as cooling.

Cryoprotectants are the chemistry that makes vitrification possible.

Cryoprotective agents (CPAs) are small molecules, often polyols or dimethyl sulfoxide-based mixtures, that penetrate cells and replace a fraction of intracellular water. They lower the freezing point, increase viscosity, and raise the concentration threshold required for ice nucleation.

No single CPA is ideal. Each trades off between vitrification potency, toxicity, osmotic stress, and permeability across tissue barriers. Real protocols use cocktails, often delivered in steps so cells equilibrate without bursting.

Cryopreservation has moved far beyond frozen cells in a vial.

Modern cryobiology spans fertility clinics, organ transplant logistics, cell therapy manufacturing, and biobanking at scale. What was once limited to small samples and simple tissues is now pushing toward whole organs and, in the laboratory, whole organisms.

Recent advances in organ vitrification, vascular perfusion, and controlled rewarming are closing the gap between what works in a dish and what works at the scale of a kidney, a heart, or an entire circulatory system. Integrated organ and tissue preservation could transform transplantation, regenerative medicine, and public health on a scale comparable to curing cancer.

One of the clearest demonstrations of that shift is CryoDAO-funded work on vitrified whole sheep ovaries: perfusion through a proprietary device, ice-free storage at liquid nitrogen temperatures, nanowarming, and replantation. That work shows a complex vascularized organ from a large mammal can recover full function after cryogenic storage, on a path toward the first FDA-approved vitrified whole organ.

Whole-organism cryopreservation is the next scale of the problem.

Preserving a whole organism means preserving circulation, organ systems, and tissue architecture together. The work is systems engineering at that scale: perfusing cryoprotectants through the vasculature, controlling cooling and rewarming uniformly across tissues, and preventing ice formation or thermal stress fractures throughout the body.

Laboratory progress is measured in steps. Renal vitrification with transplantation and long-term survival showed that a vital mammalian organ can survive the process end to end. Multi-organ models in large mammals test whether several tissues can be preserved and rewarmed together.

The CRYORAT project, funded by CryoDAO, is one of the most direct tests of reversibility at the whole-body scale: high sub-zero preservation and revival of a small mammal. That is the direction Noah and our research partners are pushing: rigorous protocols, reproducible outcomes, and scale that matches real biology rather than isolated samples.

Whole-organism cryopreservation opens paths far beyond any single use case.

The same core science that preserves organs in the lab applies wherever life must survive extremes: trauma, distance, time, and uncertainty. That is what Noah is building: Cryopets in the field today, and research that pushes whole-organism cryopreservation toward human biostasis. Done well, preservation retains the biological structure and information future medicine will need to restore.

Human cryopreservation

Medical biostasis offers a bridge when today's medicine cannot yet treat a terminal condition. The scientific question is not whether cold stops decay, but whether enough neural and cellular information can be preserved under optimal conditions to permit eventual restoration. Decades of cryobiology literature, including work on brain viability, connectome preservation, and memory retention after vitrification, suggest that case deserves serious research attention.

Pet cryopreservation

Companion animals share vascular anatomy and clinical pathways similar to humans at a scale where whole-organism protocols can be tested and refined in practice. Cryopets, Noah's active program, applies medical-grade cryosleep for pets today while generating the operational and scientific feedback loops that larger-scale preservation requires.

Cryo for space travel

Long-duration missions impose biological limits that engineering alone cannot remove. A crewed Mars round trip spans on the order of 900 days off Earth; lunar outposts offer no rapid evacuation, and trauma care on the surface may require stabilizing an injured astronaut for weeks before definitive help is possible. Biostasis research, from induced torpor to cryogenic vitrification, aims to extend that window, cut life-support mass, and reduce radiation and health exposure during transit.

Medical evacuation and trauma

Controlled hypothermia and biostasis can extend the window between injury and definitive care, buying time for patients who cannot reach a hospital immediately, from battlefield trauma to rural emergency medicine.

Organ banking and regenerative medicine

A world with vitrified organ banks would transform transplant medicine, reduce discard rates, and pair with tissue engineering as regenerative therapies mature.

Why Noah works on whole-organism cryopreservation.

We believe whole-organism cryopreservation is the most consequential technology of our time. It is the bridge between two ambitions that have defined human striving for as long as we have looked up at the night sky: defeating death, and reaching the stars.

That is why Noah exists. We are here to bring reversible human cryopreservation to the world. The science is hard, but the payoff is eternal.

Breakthrough papers that support the field.

Decades of peer-reviewed work underpins reversible cryopreservation for whole organisms, from early brain viability studies to organ vitrification, memory retention after cooling, and connectome preservation. Explore some of the most impactful papers in the field below.

Explore